日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Early Symptom Response in Patients With Uncomplicated Urinary Tract Infection Treated With Gepotidacin or Nitrofurantoin: Pooled Analysis From Two Pivotal Phase 3 Studies

使用吉泊他辛或呋喃妥因治疗单纯性尿路感染患者的早期症状反应:两项关键性3期研究的汇总分析

Sheets, Amanda J; Dennison, Jeremy; Pogue, Jason M; Kaye, Keith S; Perry, Caroline; Millns, Helen; Díaz-Regañón, Jazmín; Janmohamed, Salim

P-1311. Community-associated carbapenem-resistant gram-negative bacilli infection in Japan

P-1311. 日本社区获得性耐碳青霉烯类革兰氏阴性杆菌感染

Hernández-Aguilar, Claudia; Méndez, Juana Isabel; Romero-Galindo, Raúl; Rojas, Mario; Balderas, David; Ponce, Pedro; Valencia-Hernández, Joel Eduardo; Domínguez-Pacheco, Flavio Arturo; Tun, May Thet Hmu; Soe, Khin Htet Htet; Lwin, Khant Kaung Htet; Polepalli, Krishna Vamsy; Lin, May Yee; Paudel, Sumitra; Zeng, Desen; Li, Andrew; Klepper, Cameron; Roshni, Prarath; Iqbal, Saira P; Chung, Jessica; Lin, Yu Shia; Chapnick, Edward; Castro, Maximiliano Gabriel; Beloso, Melina Tatiana; Amato, Ana Paula; Blanc, Joaquín Ignacio Coduri Anthonioz; Rottoli, Erwin Alexander; Cravero, Guillermina; Agüero, Agustina; Martínez, Agustín; Priotti, Luciano; Pujato, Mateo; Portillo, Joaquín; Cena, Gisela Muñoz; Colussi, Andrea Gómez; Argarañá, Fernanda; Galluccio, Federico Rafael; Matsuo, Takahiro; Borgonovo, Fabio; Lahr, Brian; Petri, Francesco; Igwilo-Alaneme, Rita; Alvarez Mulett, Sergio L; Alavi, Amin; Tande, Aaron J; Berbari, Elie F; Hong, David K; Ascioglu, Sibel; Bhatt, Nivedita; Critchley, Ian A; Gaber, Masha; Gasink, Leanne B; Hamed, Kamal A; Hutchins, Aubri; McDonnell, Aoibhinn; Otiker, Tal; Sánchez-Pearson, Yasmin; Sheets, Amanda J; Sotolongo, Dan; Sprys, Mike; Torumkuney, Didem; Wrzosek, Kamil; Peppercorn, Amanda; Kawamoto, Yuya; Uemura, Kohei; Matsumara, Yasufumi; Hase, Ryota; Kato, Hideaki; Matono, Takashi; Itoh, Naoya; Hashimoto, Takehiro; Yamamoto, Go; Mawatari, Momoko; Tsutsumi, Takeya; Suzuki, Tetsuya; Ohyama, Koji; Suzuki, Masahiro; Sakurai, Aki; Hayakawa, Kayoko; van Duin, David; Ohmagari, Norio; Doi, Yohei; Saito, Sho

173. Oral Tebipenem Pivoxil Hydrobromide versus Intravenous Imipenem-Cilastatin in Patients with Complicated Urinary Tract Infections or Acute Pyelonephritis: Efficacy and Safety Results from the Phase 3 PIVOT-PO study

173. 口服替比培南匹酯氢溴酸盐与静脉注射亚胺培南-西司他丁治疗复杂性尿路感染或急性肾盂肾炎患者的疗效和安全性比较:PIVOT-PO III期研究的疗效和安全性结果

Ungar, Michael; Arends, B; Ahmetagic, D; Van Amsterdam, W A C; Van Osch, D; Mast, T P; Vessies, M B; Tonino, W A L; Van 'T Veer, M; Teske, A J; Van Der Harst, P; Van De Leur, R R; Van Es, R; Katz, Morgan; Stoltzfus, Heather; Maragakis, Lisa L; Speck, Kathleen; Miller, Melissa A; Ahn, Roy; Titus, Jennifer; Gao, Yue; Dullabh, Prashila; Squires, Lauren; Lin, Leyi; Andrews, Caylin; Jump, Robin; Cintron, Isabel; Duluc, Carmen A; Andino, Maria Laura; Mendez-Reyes, Laura P; Andujar, Claudio; Abud, Caridad; Tavarez, Karla; Flavia, Ana Lia; Rodriguez, Daliah; Abreu, Rosa; Peña, Milagros; Lora-Rodriguez, Hector Jose; Paulino-Ramirez, Robert; Hong, David K; Ascioglu, Sibel; Bhatt, Nivedita; Critchley, Ian A; Gaber, Masha; Gasink, Leanne B; Hamed, Kamal A; Hutchins, Aubri; McDonnell, Aoibhinn; Otiker, Tal; Sánchez-Pearson, Yasmin; Sheets, Amanda J; Sotolongo, Dan; Sprys, Mike; Torumkuney, Didem; Wrzosek, Kamil; Peppercorn, Amanda

Efficacy and in vitro activity of gepotidacin against bacterial uropathogens, including drug-resistant phenotypes, in females with uncomplicated urinary tract infections: results from two global, pivotal, phase 3 trials (EAGLE-2 and EAGLE-3)

吉泊他辛对包括耐药表型在内的细菌性泌尿道病原体的疗效和体外活性,用于治疗女性非复杂性尿路感染:两项全球关键性 3 期试验(EAGLE-2 和 EAGLE-3)的结果

Scangarella-Oman, Nicole E; Butler, Deborah L; Breton, John; Brown, Derrek; Kasapidis, Cara; Millns, Helen; Huang, Chun; Perry, Caroline R; Sheets, Amanda J; Dennison, Jeremy; Janmohamed, Salim

Efficacy and in vitro activity of gepotidacin against bacterial uropathogens, including subsets with molecularly characterized resistance mechanisms and genotypes/epidemiological clones, in females with uncomplicated urinary tract infections: results from two global, pivotal, phase 3 trials (EAGLE-2 and EAGLE-3)

吉泊他辛对包括具有分子特征耐药机制和基因型/流行病学克隆的亚群在内的细菌性泌尿道病原体的疗效和体外活性,针对患有非复杂性尿路感染的女性:两项全球关键性 3 期试验(EAGLE-2 和 EAGLE-3)的结果

Scangarella-Oman, Nicole E; Butler, Deborah L; Breton, John; Brown, Derrek; Kasapidis, Cara; Sheets, Amanda J

Impact of updated regulatory guidelines on study results in contemporary uncomplicated urinary tract infection clinical trials and implications for trial conduct and drug development: a comparative analysis with EAGLE-2 and EAGLE-3

更新后的监管指南对当代非复杂性尿路感染临床试验研究结果的影响及其对试验开展和药物研发的意义:与EAGLE-2和EAGLE-3的比较分析

Wagenlehner, Florian; Kaye, Keith S; Talan, David A; Sheets, Amanda J; Scangarella-Oman, Nicole E; Jarvis, Emily; Dennison, Jeremy; Janmohamed, Salim; Helgeson, Matthew; Perry, Caroline

Contribution of Bordetella filamentous hemagglutinin and adenylate cyclase toxin to suppression and evasion of interleukin-17-mediated inflammation.

博德特氏菌丝状血凝素和腺苷酸环化酶毒素对抑制和逃避白细胞介素-17介导的炎症的贡献

Henderson Michael W, Inatsuka Carol S, Sheets Amanda J, Williams Corinne L, Benaron David J, Donato Gina M, Gray Mary C, Hewlett Erik L, Cotter Peggy A